Aerovate Therapeutics, Inc. (NasdaqGM: AVTE) Loss Submission Form

Kuznicki Law is investigating the proposed merger of Aerovate Therapeutics, Inc. (NasdaqGM: AVTE) and Jade Biosciences. Pursuant to the terms of the agreement, shareholders of Aerovate will own approximately 1.6%  of the combined company. Kuznicki Law is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Aerovate shareholders.